Erica Jackson - Oric Pharmaceut | 人才画像

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 57 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Nab-Paclitaxel in Patients with Advanced Solid Tumors

CANCER RESEARCH COMMUNICATIONSno. 9 (2024): 2415-2426

引用0浏览0WOS引用

Figure 1 from ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Nab-Paclitaxel in Patients with Advanced Solid Tumors

Christopher T. Chen,Vishesh Khanna,Shivaani Kummar, Raghad M. Abdul-Karim,David Sommerhalder,Anthony W. Tolcher, Naoto T. Ueno,Sarah Lindsey Davis, Douglas W. Orr,Erika Hamilton,Manish R. Patel, Alexander I. Spira,Shekeab Jauhari,Vaia Florou,Maureen Duff,Rongda Xu, Jian Wang,Shravani R. Barkund,Haiying Zhou,Aleksandr Pankov,Wayne Kong,Nadine S. Jahchan,Erica L. Jackson,Jessica D. Sun, Melissa R. Junttila,Pratik S. Multani, Anneleen Daemen,Edna Chow Maneval,Pamela N. Munster

crossref（2024）

引用0浏览0引用

Abstract PO2-18-04: STX-478 is a Potentially Best-in-class Mutant-Selective PI3Kα Inhibitor That Demonstrates Robust Efficacy in ER+ Breast Cancer Models As Monotherapy and in Combination with Standard of Care Agents

Trang Tieu,Leonard Buckbinder, David St. Jean,Samantha Manimala,Gregory Dowdell, Michael Huff,Jacob Alltucker,Erica Jackson,Angel Guzman-Perez,Darrin Stuart

Cancer Researchno. 9_Supplement (2024): PO2-18

引用0浏览0引用

Supplementary Table 1 from ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Nab-Paclitaxel in Patients with Advanced Solid Tumors

crossref（2024）

引用0浏览0引用

Table 2 from ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Nab-Paclitaxel in Patients with Advanced Solid Tumors

crossref（2024）

引用0浏览0引用

Supplementary Table 2 from ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Nab-Paclitaxel in Patients with Advanced Solid Tumors

Christopher T. Chen,Vishesh Khanna,Shivaani Kummar, Raghad M. Abdul-Karim,David Sommerhalder,Anthony W. Tolcher,Naoto T. Ueno,Sarah Lindsey Davis, Douglas W. Orr,Erika Hamilton,Manish R. Patel, Alexander I. Spira,Shekeab Jauhari,Vaia Florou,Maureen Duff,Rongda Xu, Jian Wang,Shravani R. Barkund,Haiying Zhou,Aleksandr Pankov,Wayne Kong,Nadine S. Jahchan,Erica L. Jackson,Jessica D. Sun, Melissa R. Junttila,Pratik S. Multani, Anneleen Daemen,Edna Chow Maneval,Pamela N. Munster

crossref（2024）

引用0浏览0引用

Figure 2 from ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Nab-Paclitaxel in Patients with Advanced Solid Tumors

crossref（2024）

引用0浏览0引用

Figure 3 from ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Nab-Paclitaxel in Patients with Advanced Solid Tumors

Christopher T. Chen,Vishesh Khanna,Shivaani Kummar, Raghad M. Abdul-Karim,David Sommerhalder,Anthony W. Tolcher,Naoto T. Ueno,Sarah Lindsey Davis, Douglas W. Orr,Erika Hamilton,Manish R. Patel, Alexander I. Spira,Shekeab Jauhari,Vaia Florou,Maureen Duff,Rongda Xu, Jian Wang,Shravani R. Barkund,Haiying Zhou,Aleksandr Pankov,Wayne Kong,Nadine S. Jahchan,Erica L. Jackson,Jessica D. Sun, Melissa R. Junttila,Pratik S. Multani, Anneleen Daemen,Edna Chow Maneval,Pamela N. Munster

crossref（2024）

引用0浏览0引用

Table 1 from ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Nab-Paclitaxel in Patients with Advanced Solid Tumors

Christopher T. Chen,Vishesh Khanna,Shivaani Kummar, Raghad M. Abdul-Karim,David Sommerhalder,Anthony W. Tolcher,Naoto T. Ueno,Sarah Lindsey Davis, Douglas W. Orr,Erika Hamilton,Manish R. Patel, Alexander I. Spira,Shekeab Jauhari,Vaia Florou,Maureen Duff,Rongda Xu, Jian Wang,Shravani R. Barkund,Haiying Zhou,Aleksandr Pankov,Wayne Kong,Nadine S. Jahchan,Erica L. Jackson,Jessica D. Sun, Melissa R. Junttila,Pratik S. Multani, Anneleen Daemen,Edna Chow Maneval,Pamela N. Munster

crossref（2024）

引用0浏览0引用

Precision Oncology Comes of Age: Designing Best-in-Class Small Molecules by Integrating Two Decades of Advances in Chemistry, Target Biology, and Data Science

Darrin D. Stuart,Angel Guzman-Perez,Natasja Brooijmans,Erica L. Jackson,Gregory V. Kryukov,Adam A. Friedman,Axel Hoos

Cancer Discoveryno. 10 (2023): 2131-2149

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn